FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2536800637> ?p ?o ?g. }

• W2536800637 abstract "Graft-versus-host disease (GvHD) remains the major obstacle to successful allogeneic hematopoietic stem cell transplantation, despite of the immunosuppressive regimens administered to control T cell alloreactivity. PI3K/AKT/mTOR pathway is crucial in T cell activation and function and, therefore, represents an attractive therapeutic target to prevent GvHD development. Recently, numerous PI3K inhibitors have been developed for cancer therapy. However, few studies have explored their immunosuppressive effect. The effects of a selective PI3K inhibitor (BKM120) and a dual PI3K/mTOR inhibitor (BEZ235) on human T cell proliferation, expression of activation-related molecules, and phosphorylation of PI3K/AKT/mTOR pathway proteins were analyzed. Besides, the ability of BEZ235 to prevent GvHD development in mice was evaluated. Simultaneous inhibition of PI3K and mTOR was efficient at lower concentrations than PI3K specific targeting. Importantly, BEZ235 prevented naïve T cell activation and induced tolerance of alloreactive T cells, while maintaining an adequate response against cytomegalovirus, more efficiently than BKM120. Finally, BEZ235 treatment significantly improved the survival and decreased the GvHD development in mice. These results support the use of PI3K inhibitors to control T cell responses and show the potential utility of the dual PI3K/mTOR inhibitor BEZ235 in GvHD prophylaxis." @default.
• W2536800637 created "2016-10-28" @default.
• W2536800637 creator A5004453681 @default.
• W2536800637 creator A5015885804 @default.
• W2536800637 creator A5019363793 @default.
• W2536800637 creator A5020989412 @default.
• W2536800637 creator A5030136239 @default.
• W2536800637 creator A5034667545 @default.
• W2536800637 creator A5036295388 @default.
• W2536800637 creator A5052615349 @default.
• W2536800637 creator A5058517145 @default.
• W2536800637 creator A5061747149 @default.
• W2536800637 creator A5080760606 @default.
• W2536800637 date "2016-10-20" @default.
• W2536800637 modified "2023-10-17" @default.
• W2536800637 title "Targeting of PI3K/AKT/mTOR pathway to inhibit T cell activation and prevent graft-versus-host disease development" @default.
• W2536800637 cites W1058891070 @default.
• W2536800637 cites W1493453469 @default.
• W2536800637 cites W1499167782 @default.
• W2536800637 cites W1510797800 @default.
• W2536800637 cites W1544331058 @default.
• W2536800637 cites W1550192924 @default.
• W2536800637 cites W1616716935 @default.
• W2536800637 cites W1871566045 @default.
• W2536800637 cites W1919300793 @default.
• W2536800637 cites W1944331591 @default.
• W2536800637 cites W1964063928 @default.
• W2536800637 cites W1964559779 @default.
• W2536800637 cites W1974625493 @default.
• W2536800637 cites W1976460197 @default.
• W2536800637 cites W1976910093 @default.
• W2536800637 cites W1976972237 @default.
• W2536800637 cites W1981904703 @default.
• W2536800637 cites W1984621921 @default.
• W2536800637 cites W1999198216 @default.
• W2536800637 cites W2000623020 @default.
• W2536800637 cites W2007939817 @default.
• W2536800637 cites W2010849232 @default.
• W2536800637 cites W2011660868 @default.
• W2536800637 cites W2013036515 @default.
• W2536800637 cites W2017958614 @default.
• W2536800637 cites W2018872626 @default.
• W2536800637 cites W2021566831 @default.
• W2536800637 cites W2025938193 @default.
• W2536800637 cites W2027448345 @default.
• W2536800637 cites W2028489100 @default.
• W2536800637 cites W2035169670 @default.
• W2536800637 cites W2035216470 @default.
• W2536800637 cites W2035557966 @default.
• W2536800637 cites W2069937776 @default.
• W2536800637 cites W2080196128 @default.
• W2536800637 cites W2086338749 @default.
• W2536800637 cites W2087667264 @default.
• W2536800637 cites W2089367238 @default.
• W2536800637 cites W2092191165 @default.
• W2536800637 cites W2095065294 @default.
• W2536800637 cites W2097247231 @default.
• W2536800637 cites W2100714842 @default.
• W2536800637 cites W2103116442 @default.
• W2536800637 cites W2110881834 @default.
• W2536800637 cites W2116811386 @default.
• W2536800637 cites W2118754985 @default.
• W2536800637 cites W2119319172 @default.
• W2536800637 cites W2122545452 @default.
• W2536800637 cites W2131696316 @default.
• W2536800637 cites W2134138119 @default.
• W2536800637 cites W2135196289 @default.
• W2536800637 cites W2145885463 @default.
• W2536800637 cites W2148181678 @default.
• W2536800637 cites W2151789399 @default.
• W2536800637 cites W2151982291 @default.
• W2536800637 cites W2154492083 @default.
• W2536800637 cites W2154871907 @default.
• W2536800637 cites W2155759076 @default.
• W2536800637 cites W2157822826 @default.
• W2536800637 cites W2157983986 @default.
• W2536800637 cites W2158305336 @default.
• W2536800637 cites W2274141080 @default.
• W2536800637 doi "https://doi.org/10.1186/s13045-016-0343-5" @default.
• W2536800637 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5072323" @default.
• W2536800637 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27765055" @default.
• W2536800637 hasPublicationYear "2016" @default.
• W2536800637 type Work @default.
• W2536800637 sameAs 2536800637 @default.
• W2536800637 citedByCount "63" @default.
• W2536800637 countsByYear W25368006372017 @default.
• W2536800637 countsByYear W25368006372018 @default.
• W2536800637 countsByYear W25368006372019 @default.
• W2536800637 countsByYear W25368006372020 @default.
• W2536800637 countsByYear W25368006372021 @default.
• W2536800637 countsByYear W25368006372022 @default.
• W2536800637 countsByYear W25368006372023 @default.
• W2536800637 crossrefType "journal-article" @default.
• W2536800637 hasAuthorship W2536800637A5004453681 @default.
• W2536800637 hasAuthorship W2536800637A5015885804 @default.
• W2536800637 hasAuthorship W2536800637A5019363793 @default.
• W2536800637 hasAuthorship W2536800637A5020989412 @default.
• W2536800637 hasAuthorship W2536800637A5030136239 @default.
• W2536800637 hasAuthorship W2536800637A5034667545 @default.
• W2536800637 hasAuthorship W2536800637A5036295388 @default.

• next